Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06098430 · ClinicalTrials.gov registry record
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
A clinical trial of Nodular Lymphocyte-Predominant Hodgkin Lymphoma, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- 100
- Enrollment target
- 5
- Study locations
NCT06098430: Recruiting study of Nodular Lymphocyte-Predominant Hodgkin Lymphoma, sponsored by St. Jude Children's Research Hospital.
NCT06098430 is a study of Nodular Lymphocyte-Predominant Hodgkin Lymphoma that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 100 participants. The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06098430, a study of Nodular Lymphocyte-Predominant Hodgkin Lymphoma, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 5
- Study locations
Study Summary
There is a pressing need to measure patient-reported symptoms in patients of all ages diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). This study aims to measure longitudinal symptom burden and treatment tolerability utilizing validated patient-reported outcomes (PROs) instruments. Primary Objective: * To develop the data collection infrastructure required to prospectively collect longitudinal electronic patient-reported outcomes (PROs) survey instruments in adult and pediatric patients diagnosed with NLPHL. Secondary Objective: * To examine differences in baseline and longitudinal changes in PROs based on disease characteristics, disease status, and treatment strategies among adult and pediatric patients diagnosed with NLPHL.
Primary Outcome
Percentage of survey completion at different timepoints
Conditions Studied
Study Locations (5)
New York
- Memorial Sloan Kettering Cancer Center - New York
- The University of Rochester Medical Center - Rochester
Colorado
- University of Colorado Hospital - Aurora
Massachusetts
- Dana-Farber Cancer Institute - Boston
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-04-04 |
| Est. Completion | 2028-01-31 |
What NCT06098430 shows while recruiting
NCT06098430 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Nodular Lymphocyte-Predominant Hodgkin Lymphoma appearing as the primary indexed condition, and to 0 interventions.
NCT06098430 lists 5 locations in 4 states (New York, Colorado, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT06098430 about?
NCT06098430 is a clinical study titled "Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)". There is a pressing need to measure patient-reported symptoms in patients of all ages diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). This study aims to measure longitudinal symptom burden and treatment tolerability utilizing validated patient-reported outcomes (PROs) instrum...
What is the current status of trial NCT06098430?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-04-04. Estimated completion is 2028-01-31.
What conditions does trial NCT06098430 study?
This clinical trial studies the following conditions: Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Who is sponsoring clinical trial NCT06098430?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06098430 being conducted?
This trial has 5 study locations across Colorado, Massachusetts, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI